Gabapentin enacarbil: all 31 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseaseRecruitingNCT03082755Phase 4
- An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug UsersCompletedNCT06097676Phase 4Results posted
- A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedNCT03053427Phase 4Results posted
- Effect of Gabapentin Enacarbil on Opioid Consumption and Pain ScoresCompletedNCT02840240Not applicableResults posted
- The Effect of Horizant (Gabapentin Enacarbil) on AugmentationCompletedNCT02642315Not applicableResults posted
- HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use DisorderCompletedNCT02252536Phase 2Results posted
- Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment StudyCompletedNCT01668667Phase 4Results posted
- Simulated Driving Study in Restless Legs SyndromeCompletedNCT01332318Phase 2Results posted
- Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs SyndromeCompletedNCT01332305Phase 2Results posted
- Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep DisturbanceCompletedNCT00748098Phase 3Results posted
- Prevention Study in Adult Patients Suffering From Migraine HeadachesCompletedNCT00742209Phase 2Results posted
- A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)CompletedNCT00643760Phase 2Results posted
- A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)CompletedNCT00619476Phase 2Results posted
- A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin TreatmentCompletedNCT00617461Phase 2Results posted
- XP13512 vs. Placebo in Patients With Restless Legs Syndrome.CompletedNCT00365352Phase 3Results posted
- XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.CompletedNCT00333359Phase 3Results posted
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.CompletedNCT00311363Phase 3Results posted
- Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedNCT02658188Phase 3
- An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownNCT02633683Phase 4
- A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLSWithdrawnNCT02633657Phase 1
- ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825CompletedNCT02632331Phase 1
- ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and HaemodialysisCompletedNCT02629224Phase 1
- An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLSStatus unknownNCT02560766Phase 4
- Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs SyndromeStatus unknownNCT02424695Phase 4
- Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg SyndromeTerminatedNCT02117076Phase 4
- Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal ImpairmentCompletedNCT01981941Phase 4
- Drug Drug Interaction Study With Gabapentin Enacarbil and MorphineCompletedNCT01476124Phase 1
- Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy SubjectsCompletedNCT01411124Phase 1
- ASP8825 - Study in Patients With Restless Legs SyndromeCompletedNCT00530530Phase 2
- ASP 8825 - Study in Patients With Painful Diabetic PolyneuropathyTerminatedNCT00508430Phase 2
- XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.CompletedNCT00298623Phase 3